Binding sites for interferons on ovine and human endometrial membranes.
In the ewe, the major product of the preimplantation blastocyst is ovine trophoblast protein-1 (oTP-1), which is now classified as an omega-interferon (IFN). Receptors for IFN are present on sheep endometrium and vary cyclically, presumably modified by the actions of ovarian steroids. This study examined whether or not IFN receptors were present on human endometrium at any stage during the menstrual cycle. In addition, the steroid dependence of ovine endometrial IFN receptors was determined. Specific binding of 125I-labelled IFN (125I-IFN) to ovine endometrial membranes was substantially higher than binding to membranes derived from bovine spleen, human placenta or pooled human endometrium (relative specific binding 100:33:36:20). Human endometrial membrane preparations from proliferative-phase tissue showed very little specific binding (mean 0.8 +/- 0.3%, n = 4) in contrast to luteal-phase endometrium (2.1 +/- 0.3%, n = 8). Treatment of ovariectomized ewes with oestradiol-17 beta (E) resulted in significantly increased binding (117 +/- 7%) of 125I-IFN to endometrial tissues compared with tissue from ovariectomized (OvX, 75 +/- 7%), progesterone (P)-treated (69 +/- 7%), or (E + P)-treated (81 +/- 8%) groups (P < 0.05); all were compared with binding to pooled ovine luteal-phase tissue, 100%. There were no differences between the other three groups. Scatchard analysis showed binding affinity of the same order for the sheep and human receptors (Kd = 10(-10) mol L-1) but binding capacity was considerably lower for human (6.0 fmol mg-1) than for sheep (47-123 fmol mg-1) endometrium.(ABSTRACT TRUNCATED AT 250 WORDS)
Russell
D L
DL
Prince Henry's Institute of Medical Research, Clayton, Vic., Australia.
Manalo
G G
GG
Findlay
J K
JK
Salamonsen
L A
LA
D000650:Amnion / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D002417:Cattle; D002823:Chorion / Q000378:metabolism; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007372:Interferons / Q000378:metabolism*; D008183:Luteal Phase / Q000378:metabolism; D008597:Menstrual Cycle / Q000378:metabolism*; D010052:Ovariectomy; D010920:Placenta / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology; D011869:Radioligand Assay; D017471:Receptors, Interferon / Q000032:analysis* / Q000378:metabolism; D012756:Sheep; D013154:Spleen / Q000378:metabolism
D004967:Estrogens; D017471:Receptors, Interferon; D011374:Progesterone; D004958:Estradiol; D007372:Interferons